vTv Therapeutics Inc. is a clinical-stage biopharmaceutical enterprise dedicated to discovering and developing oral, small-molecule drug candidates designed to treat metabolic and autoimmune diseases. The company leverages its proprietary scientific platforms to advance innovative therapies targeting complex biological pathways, aiming to address significant medical needs in underserved therapeutic areas through rigorous clinical trial execution and strategic global partnerships.